Update

Letters Outlining FDA’s Need for More Resources to Review Promising AD Therapies

ACT-AD submitted letters to the House and Senate subcommittees that handle FDA appropriations outlining FDA’s need for more resources to review promising AD therapies.
Read House Letter
Read Senate Letter

File Attachments
  FY2008-Senate (32K PDF)
  FY2008-House (33K PDF)
Categories:
Uncategorized